Literature DB >> 25215037

Application of bedside continuous blood purification in patients with multiple organ dysfunction syndromes.

Hai-Bo Liu1, Min Zhang1, Jing-Xiao Zhang1, Yong-Jie Yin1.   

Abstract

BACKGROUND: The complications of systemic inflammatory response syndrome (SIRS) include acute lung injury, acute kidney injury, shock, and multiple organ dysfunction syndrome (MODS). In recent years, how to clear inflammatory mediators has become a hot topic in critical care medicine. Researchers hypothesize that continuous blood purification (CBP) can effectively eliminate a variety of inflammatory mediators which participate in the occurrence of MODS and adjust the immune imbalance. This study aimed to observe the effects of CBP in MODS patients.
METHODS: In this retrospective clinical study, a total of 38 MODS patients, 18 males and 20 females, were enrolled. After conventional therapy, all the patients received CBP. Biochemistry, blood gas analysis, oxygenation index, mean arterial blood pressure (MAP), acute physiology and chronic health evaluation (APACHE) II scores were monitored.
RESULTS: After CBP, the vital signs of patients were rapidly stable, and electrolyte disorders and acid-base imbalance were corrected. Renal function, blood gas, oxygenation index were all improved. MAP was increased, and APACHE II score was significantly decreased. All patients had good tolerance, stable hemodynamics, and no obvious adverse reaction on CBP compared with pre-CBP.
CONCLUSION: CBP can effectively clean toxins, correct electrolyte acid-base balance, and improve systemic inflammatory response syndrome and the organ function of MODS patients.

Entities:  

Keywords:  Continuous blood purification; Multiple organ dysfunction syndromes; Systemic inflammatory response syndrome

Year:  2012        PMID: 25215037      PMCID: PMC4129824          DOI: 10.5847/wjem.j.issn.1920-8642.2012.01.007

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  18 in total

1.  Early gut barrier dysfunction in patients with severe acute pancreatitis: attenuated by continuous blood purification treatment.

Authors:  Jianbin Zhang; Chen Yuan; Gan Hua; Ruyan Tong; Xiangfeng Luo; Zhou Ying
Journal:  Int J Artif Organs       Date:  2010-10       Impact factor: 1.595

Review 2.  Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.

Authors:  Donald E Fry
Journal:  Am Surg       Date:  2012-01       Impact factor: 0.688

Review 3.  Fluid overload in critically ill patients with acute kidney injury.

Authors:  Jorge Cerda; Geoffrey Sheinfeld; Claudio Ronco
Journal:  Blood Purif       Date:  2010-02-19       Impact factor: 2.614

4.  [Acute blood purification for septic multiple organ failure].

Authors:  Makoto Kobayashi
Journal:  Nihon Rinsho       Date:  2004-12

Review 5.  The systemic inflammatory response syndrome.

Authors:  Charles M Robertson; Craig M Coopersmith
Journal:  Microbes Infect       Date:  2006-03-23       Impact factor: 2.700

Review 6.  Blood purification for prevention and treatment of multiple organ failure.

Authors:  H Hirasawa; T Sugai; Y Ohtake; S Oda; K Matsuda; N Kitamura
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

7.  Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure.

Authors:  A Davenport
Journal:  Int J Artif Organs       Date:  2008-01       Impact factor: 1.595

8.  [Effect of continuous blood purification for management of multiple organ failure with acute renal failure].

Authors:  Lu Chen; Jiu-hong Li; Ying Jiang; Sheng-lang Zhu; Jun Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2008-05

9.  Application of "the Sequential Organ Failure Assessment (SOFA) score" in predicting outcome in ICU patients with SIRS.

Authors:  S P Acharya; B Pradhan; M N Marhatta
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2007 Oct-Dec

10.  [Individualized and comprehensive therapy for severe acute pancreatitis in early stage: analysis of 110 cases].

Authors:  Bao Liu; Ai-jun Pan; Shu-sheng Zhou; Hua Wang; Min Shao; Lin-lin Zhang
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.